These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
189 related items for PubMed ID: 8024751
1. Genetic basis of attenuation of the Sabin oral poliovirus vaccines. Minor PD, Macadam AJ, Stone DM, Almond JW. Biologicals; 1993 Dec; 21(4):357-63. PubMed ID: 8024751 [No Abstract] [Full Text] [Related]
2. Attenuation and reversion of the Sabin vaccine strains of poliovirus. Minor PD. Dev Biol Stand; 1993 Dec; 78():17-26. PubMed ID: 8388828 [Abstract] [Full Text] [Related]
3. Mutations in Sabin 2 strain of poliovirus and stability of attenuation phenotype. Rezapkin GV, Fan L, Asher DM, Fibi MR, Dragunsky EM, Chumakov KM. Virology; 1999 May 25; 258(1):152-60. PubMed ID: 10329577 [Abstract] [Full Text] [Related]
7. Development of candidates for new type 2 and type 3 oral poliovirus vaccines. Kohara M, Abe S, Yoshioka I, Nomoto A. Dev Biol Stand; 1993 May 25; 78():141-8. PubMed ID: 8388824 [Abstract] [Full Text] [Related]
8. Genetic stability and instability of the cis-acting control element of the 5' untranslated region of the poliovirus RNA. Agol VI. Dev Biol Stand; 1993 May 25; 78():11-6. PubMed ID: 8388821 [Abstract] [Full Text] [Related]
13. Determinants of monovalent oral polio vaccine mutagenesis in vaccinated elderly people. Boot HJ, Sonsma J, van Nunen F, Abbink F, Kimman TG, Buisman AM. Vaccine; 2007 Jun 11; 25(24):4706-14. PubMed ID: 17482726 [Abstract] [Full Text] [Related]
14. Studies on the attenuation phenotype of polio vaccines: poliovirus RNA polymerase derived from Sabin type 1 sequence is temperature sensitive in the uridylylation of VPg. Paul AV, Mugavero J, Yin J, Hobson S, Schultz S, van Boom JH, Wimmer E. Virology; 2000 Jun 20; 272(1):72-84. PubMed ID: 10873750 [Abstract] [Full Text] [Related]
15. Role of mutations G-480 and C-6203 in the attenuation phenotype of Sabin type 1 poliovirus. McGoldrick A, Macadam AJ, Dunn G, Rowe A, Burlison J, Minor PD, Meredith J, Evans DJ, Almond JW. J Virol; 1995 Dec 20; 69(12):7601-5. PubMed ID: 7494267 [Abstract] [Full Text] [Related]
16. Towards development of an in vitro translation test for poliovirus neurovirulence. Svitkin YV, Alpatova GA, Lipskaya GA, Maslova SV, Agol VI, Kew O, Meerovitch K, Sonenberg N. Dev Biol Stand; 1993 Dec 20; 78():27-32. PubMed ID: 8388829 [Abstract] [Full Text] [Related]
17. Identification of a consistent pattern of mutations in neurovirulent variants derived from the sabin vaccine strain of poliovirus type 2. Equestre M, Genovese D, Cavalieri F, Fiore L, Santoro R, Perez Bercoff R. J Virol; 1991 May 20; 65(5):2707-10. PubMed ID: 1850043 [Abstract] [Full Text] [Related]
18. Genetic basis of the neurovirulence of type 1 polioviruses isolated from vaccine-associated paralytic patients. Li J, Zhang LB, Yoneyama T, Yoshida H, Shimizu H, Yoshii K, Hara M, Nomura T, Yoshikura H, Miyamura T, Hagiwara A. Arch Virol; 1996 May 20; 141(6):1047-54. PubMed ID: 8712922 [Abstract] [Full Text] [Related]
19. Type 2 poliovirus recombinants isolated from vaccine-associated cases and from healthy contacts in Brazil. Friedrich F, Da-Silva EF, Schatzmayr HG. Acta Virol; 1996 Feb 20; 40(1):27-33. PubMed ID: 8886095 [Abstract] [Full Text] [Related]
20. Laboratory tests for live attenuated poliovirus vaccines. Wood DJ, Macadam AJ. Biologicals; 1997 Mar 20; 25(1):3-15. PubMed ID: 9167004 [Abstract] [Full Text] [Related] Page: [Next] [New Search]